MENU
+Compare
NDOI
Stock ticker:
AS OF
Jul 31 closing price
Price
$23.59
Change
+$0.49 (+2.12%)
Capitalization
1.8B

NDOI Endo, Inc. Forecast, Technical & Fundamental Analysis

Endo Inc is a diversified pharmaceutical company... Show more

NDOI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NDOI with price predictions
Aug 12, 2025

NDOI in upward trend: price rose above 50-day moving average on July 24, 2025

NDOI moved above its 50-day moving average on July 24, 2025 date and that indicates a change from a downward trend to an upward trend. In of 4 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for NDOI crossed bullishly above the 50-day moving average on July 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NDOI advanced for three days, in of 22 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NDOI moved out of overbought territory on July 30, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 5 similar instances where the indicator moved out of overbought territory. In of the 5 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 9 cases where NDOI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NDOI as a result. In of 27 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

NDOI broke above its upper Bollinger Band on July 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NDOI entered a downward trend on July 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.598) is normal, around the industry mean (20.208). P/E Ratio (0.000) is within average values for comparable stocks, (72.099). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.497). NDOI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (0.803) is also within normal values, averaging (40.630).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NDOI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NDOI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
NDOI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.930.66
+2.96%
GameStop Corp
BTC.X120172.9100001441.460900
+1.21%
Bitcoin cryptocurrency
AAPL229.652.47
+1.09%
Apple
SPY642.696.77
+1.06%
SPDR® S&P 500® ETF
TSLA340.841.81
+0.53%
Tesla

NDOI and Stocks

Correlation & Price change

A.I.dvisor tells us that NDOI and CTOR have been poorly correlated (+-22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDOI and CTOR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDOI
1D Price
Change %
NDOI100%
N/A
CTOR - NDOI
-22%
Poorly correlated
-1.74%

Groups containing NDOI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDOI
1D Price
Change %
NDOI100%
N/A
Pharmaceuticals
category (393 stocks)
9%
Poorly correlated
+0.32%
Pharmaceuticals: Generic
category (227 stocks)
4%
Poorly correlated
+0.26%